Research Catalog
The truth about the drug companies : how they deceive us and what to do about it
- Title
- The truth about the drug companies : how they deceive us and what to do about it / Marcia Angell.
- Author
- Angell, Marcia.
- Publication
- New York : Random House, [2004], ©2004.
- Supplementary Content
Items in the Library & Off-site
Filter by
2 Items
Status | Format | Access | Call Number | Item Location |
---|---|---|---|---|
Text | Request in advance | HD9666.5 .A74 2004 | Off-site | |
Not available - Please for assistance. | Text | Use in library | Off-site |
Holdings
Details
- Description
- xx, 305 pages; 25 cm
- Summary
- Angell watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices.
- "During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the growing corruption of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled with and increasingly failed to keep up with spiraling prescription drug prices. Now, in this new book, Angell exposes the truth of what the pharmaceutical industry has become - and argues for essential, long-overdue change."--BOOK JACKET.
- Subjects
- Industrie pharmaceutique
- Advertising > Drugs
- Prescription pricing
- Industrie pharmaceutique > États-Unis > Coût
- Advertising > Drugs > United States
- Pharmaceutical industry > United States > Costs
- Médicaments > Prix > États-Unis
- Prescription pricing > United States
- Pharmaceutical industry > Costs
- Winst
- Ethiek
- United States
- Médicaments > Publicité > États-Unis
- Brevets
- Farmaceutische industrie
- Drug Industry > economics
- Fixation des prix
- Pharmaceutical Preparations > economics
- Drugs > Prices > United States
- Marketing
- Etats-Unis d'Amérique
- Médicaments > Recherche > États-Unis > Finances
- Advertising as Topic
- Drugs > Research > United States > Finance
- Médicaments > Politique gouvernementale > États-Unis
- Pharmaceutical policy > United States
- Drugs > Research > Finance
- Publicité
- Bibliography (note)
- Includes bibliographical references and index.
- Contents
- Introduction : Drugs are different -- 1. The $200 billion colossus -- 2. The creation of a new drug -- 3. How much does the pharmaceutical industry really spend on R & D? -- 4. Just how innovative is this industry? -- 5. "Me-too" drugs : the main business of the pharmaceutical industry -- 6. How good are new drugs? -- 7. The hard sell : lures, bribes, and kickbacks -- 8. Marketing masquerading as education -- 9. Marketing masquerading as research -- 10. Patent games : stretching out monopolies -- 11. Buying influence : how the industry makes sure it gets its way -- 12. Is the party over? -- 13. How to save the pharmaceutical industry--and get our money's worth -- Afterword.
- ISBN
- 0375508465
- 9780375508462
- 9780375760945
- 0375760946
- LCCN
- 2004041212
- OCLC
- ocm54035188
- 54035188
- SCSB-9617349
- Owning Institutions
- Columbia University Libraries